1Suppliers
10Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

SWK Holdings Corp (SWKH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

14Total relationships
1Distinct source URLs
4High confidence
0.743Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

SWK Holdings Corp Suppliers

TickerNameConfidenceEvidence
ETON Eton Pharmaceuticals, Inc. 72% Reciprocal relationship from ETON graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from ETON graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from ETON g…

SWK Holdings Corp Customers

TickerNameConfidenceEvidence
CUSTOMER CUSTOMER 90% For the year ended December 31, 2025 and 2024, the Company had one customer that accounted for approximately 97.5 % and 96.0 % of pharmaceutical development revenues, respectively.
ETON Eton Pharmaceuticals, Inc. 72% Reciprocal relationship from ETON graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from ETON graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from ETON g…
RPRX Royalty Pharma plc 72% key personnel were to join or form a competitor, our business could similarly suffer a material adverse effect. In addition, we have very few employees, so the loss of any employee could be disruptiv…
RPRX Royalty Pharma plc 72% Reciprocal relationship from RPRX graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from RPRX graph: Reciprocal relationship from SWKH graph: key personnel were to join or form …
RWAY Runway Growth Finance Corp. 72% ents, considering a “management approach” concept as the basis for identifying reportable segments. The management approach is based on the way that management organizes the segments within the Compa…
RWAY Runway Growth Finance Corp. 72% Reciprocal relationship from RWAY graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from RWAY graph: Reciprocal relationship from SWKH graph: Reciprocal relationship from RWAY g…
BEST-ABT-INC BEST-ABT-INC 62% ns Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance re…
ENTERIS-BIOPHARMA-INC ENTERIS-BIOPHARMA-INC 62% form. The Company was originally incorporated in California in July 1996 and reincorporated in Delaware in September 1999. The Company is headquartered in Dallas, Texas, and had 9 full-time employees…
FLOWONIX-MEDICAL-INC FLOWONIX-MEDICAL-INC 62% ns Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance re…
IDEAL-IMPLANT-INC IDEAL-IMPLANT-INC 62% ns Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, interest and accounts receivable, finance re…

SWK Holdings Corp Debt Obligations

InstrumentDescriptionConfidenceEvidence
SWKH-DEBT-12844 Warrants outstanding: 347222 90% xbrl warrant detail from xbrl 2025-12-31.
SWKH-DEBT Debt stack $32.6M 90% Market cache reports total debt of $32.6M.

SWK Holdings Corp Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for SWK Holdings Corp.

SWK Holdings Corp Ownership

HolderNameConfidenceEvidence
SWKH-OWNER-CARLSON-CAPITAL-L-P Carlson Capital, L.P. 90% 13F overlay lists Carlson Capital, L.P. as top holder; 59 tracked holders.

SWK Holdings Corp Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
RWAY Runway Growth Finance Corp. 100.00 1 ['customer']
NUVL Nuvalent, Inc. 100.00 2
JNJ Johnson & Johnson 100.00 2
ETON Eton Pharmaceuticals, Inc. 100.00 1 ['customer', 'supplier']
RVMD Revolution Medicines, Inc. 100.00 2
RPRX Royalty Pharma plc 100.00 1 ['customer']
PTCT PTC Therapeutics, Inc. 50.00 2
NOTE FiscalNote Holdings, Inc. 50.00 2
PRTC PureTech Health plc 50.00 2
MNPR Monopar Therapeutics Inc. 50.00 2
MA Mastercard Incorporated 50.00 2
MRK Merck & Co., Inc. 50.00 2
NERV Minerva Neurosciences, Inc. 50.00 2
SWKHL SWK Holdings Corp 50.00 2
ORANY ORANGE 50.00 2
AMMTEK AMMTEK 50.00 2
VRTX Vertex Pharmaceuticals Incorporated 50.00 2
HROW Harrow, Inc. 50.00 2
NBIX Neurocrine Biosciences, Inc. 50.00 2
CYTK Cytokinetics, Incorporated 24.13 2
🔐
SWKH
Unlock SWKH Supply Chain Data
Verified relationships include:
ETONEton Pharmaceuticals, Inc.Supplier72%
CUSTOMERCUSTOMERCustomer90%
ETONEton Pharmaceuticals, Inc.Customer72%
+10 more relationships locked
Subscribe, View plans →